VERACYTE, INC. (VCYT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 60M 120M 180M Q3 '21: 60.4M Q4 '21: 67.3M Q1 '22: 67.8M Q2 '22: 72.9M Q3 '22: 75.6M Q4 '22: 80.3M Q1 '23: 82.4M Q2 '23: 90.3M Q3 '23: 90.1M Q4 '23: 98.2M Q1 '24: 96.8M Q2 '24: 114.4M Q3 '24: 115.9M Q4 '24: 118.6M Q1 '25: 114.5M Q2 '25: 130.2M Q3 '25: 131.9M Q4 '25: 140.6M Q1 '26: 139.1M Q2 '26: 150.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 40M 80M 120M Q1 '23: 51.4M Q2 '23: 55.8M Q3 '23: 57.7M Q4 '23: 64.8M Q1 '24: 62.5M Q2 '24: 77.9M Q3 '24: 79M Q4 '24: 78.8M Q1 '25: 79.5M Q2 '25: 89.8M Q3 '25: 91.3M Q4 '25: 102M Q1 '26: 101.2M Q2 '26: 108.5M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '21: -16.7M Q4 '21: -12.3M Q1 '22: -15.2M Q2 '22: -10.7M Q3 '22: -9.7M Q4 '22: -5.4M Q1 '23: -10.5M Q2 '23: -8.1M Q3 '23: -31.7M Q4 '23: -35.5M Q1 '24: -4.7M Q2 '24: 4.6M Q3 '24: 12M Q4 '24: 4.2M Q1 '25: 2.9M Q2 '25: -5.3M Q3 '25: 22.9M Q4 '25: 37.2M Q1 '26: 22.6M Q2 '26: 23M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-30M -15M 0 15M 30M 45M Q3 '21: -14.1M Q4 '21: -10.5M Q1 '22: -14.5M Q2 '22: -9.5M Q3 '22: -8.7M Q4 '22: -3.8M Q1 '23: -8.1M Q2 '23: -8.4M Q3 '23: -29.6M Q4 '23: -28.3M Q1 '24: -1.9M Q2 '24: 5.7M Q3 '24: 15.2M Q4 '24: 5.1M Q1 '25: 7M Q2 '25: -980K Q3 '25: 19.1M Q4 '25: 41.1M Q1 '26: 28.7M Q2 '26: 25.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 3.5M 7M 10.5M Q1 '15: 4.6M Q2 '15: 5.1M Q3 '15: 5.6M Q4 '15: 6.2M Q1 '16: 6.3M Q2 '16: 6.3M Q3 '16: 6.4M Q4 '16: 6.5M Q1 '17: 6.3M Q2 '17: 7M Q3 '17: 7.2M Q4 '17: 7.8M Q1 '18: 7.9M Q2 '18: 8.2M Q3 '18: 8.3M Q4 '18: 8.7M Q1 '19: 8.5M Q2 '19: 8.8M Q3 '19: 9.1M Q4 '19: 9.7M Q2 '15 Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19

Operating Cash Flow Quarterly

-20M 0 20M 40M 60M Q2 '21: 1.9M Q3 '21: -1.4M Q1 '22: -8.9M Q2 '22: -363K Q3 '22: 7M Q4 '22: 9.7M Q1 '23: -2.2M Q2 '23: 16.7M Q3 '23: 14.2M Q4 '23: 15.6M Q1 '24: -9M Q2 '24: 29.6M Q3 '24: 30M Q4 '24: 24.5M Q1 '25: 5.4M Q2 '25: 33.6M Q3 '25: 44.8M Q4 '25: 52.6M Q1 '26: 35.2M Q2 '26: 45.8M Q3 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-20M 0 20M 40M 60M Q2 '21: 360K Q3 '21: -3.2M Q1 '22: -11.3M Q2 '22: -2.9M Q3 '22: 5.3M Q4 '22: 7.9M Q1 '23: -3.2M Q2 '23: 13M Q3 '23: 11.4M Q4 '23: 13.1M Q1 '24: -11.1M Q2 '24: 26.8M Q3 '24: 27.7M Q4 '24: 20.4M Q1 '25: 3.5M Q2 '25: 32.3M Q3 '25: 42M Q4 '25: 48.8M Q1 '26: 32.3M Q2 '26: 43M Q3 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q2 '20: 50.2M Q3 '20: 54.9M Q1 '21: 63.3M Q2 '21: 67.3M Q3 '21: 69.7M Q1 '22: 71.2M Q2 '22: 71.5M Q3 '22: 71.7M Q1 '23: 72.2M Q2 '23: 72.5M Q3 '23: 72.8M Q1 '24: 74.8M Q2 '24: 77.2M Q3 '24: 78.5M Q1 '25: 80.1M Q2 '25: 78.4M Q3 '25: 79.7M Q1 '26: 81.3M Q2 '26: 82.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q3 '21: -1.13 Q4 '21: -1.13 Q1 '22: -0.67 Q2 '22: -0.67 Q3 '22: -0.59 Q4 '22: -0.50 Q1 '23: -0.41 Q2 '23: -0.40 Q3 '23: -0.69 Q4 '23: -1.02 Q1 '24: -0.93 Q2 '24: -0.74 Q3 '24: -0.14 Q4 '24: 0.30 Q1 '25: 0.41 Q2 '25: 0.33 Q3 '25: 0.38 Q4 '25: 0.82 Q1 '26: 1.08 Q2 '26: 1.40 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.